Hypothalamic Abnormalities in Schizophrenia: Sex Effects and Genetic Vulnerability

Biological Psychiatry

Volumn 61, Issue 8, 2007, Pages 935-945

  Goldstein, Jill M ^a,b,c,d,e   Seidman, Larry J ^c,d,e   Makris, Nikos ^a   Ahern, Todd ^c,d,e   O'Brien, Liam M ^f   Caviness Jr , Verne S ^e   Kennedy, David N ^e   Faraone, Stephen V ^g   Tsuang, Ming T ^c,d,h,i  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Division of Women's Health   (United States)

^c MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f Health Services and Department of Biology   (United States)

^g State University of New York Upstate Medical University: College of Medicine   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic vulnerability; hypothalamus; MRI; schizophrenia; sex differences

Indexed keywords

ADULT; AGED; ANTERIOR HYPOTHALAMUS; ANXIETY; AROUSAL; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONSANGUINEOUS MARRIAGE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION; GROUPS BY AGE; HUMAN; HYPOTHALAMUS; MALE; MAMMILLARY BODY; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RELATIVE; SCHIZOPHRENIA; SEX DIFFERENCE; SEX RATIO; SIMPLE SCHIZOPHRENIA; STATISTICAL MODEL; THALAMUS NUCLEUS;

ADULT; AGED; ANXIETY; BRAIN MAPPING; CASE-CONTROL STUDIES; FAMILY HEALTH; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HYPOTHALAMUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX CHARACTERISTICS; STATISTICS, NONPARAMETRIC;

EID: 33947732194     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.06.027     Document Type: Article

References (91)

1. Allen L.S., Hines M., Shryne J.E., and Gorski R.A. Two sexually dimorphic cell groups in the human brain. J Neurosci 9 (1989) 497-506
2. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., and Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 128 (2005) 1301-1313
3. Beckmann H., Lang R.E., and Gattaz W.F. Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 10 (1985) 187-191
4. Beltramino C., and Taleisnik S. Inhibitory influence of the nuclei of the posterior hypothalamus on the pro-oestrous surge of LH. Acta Endocrinol (Copenh) 105 (1984) 433-440
5. Briess D., Cotter D., Doshi R., and Everall I. Mamillary body abnormalities in schizophrenia. Lancet 352 (1998) 789-790
6. Brooker B.H., and Cyr J.J. Tables for clinicians to use to convert WAIS-R short forms. J Clin Psychol 42 (1986) 982-986
7. Byne W., Lasco M.S., Kemether E., Shinwari A., Edgar M.A., Morgello S., et al. The interstitial nuclei of the human anterior hypothalamus: An investigation of sexual variation in volume and cell size, number and density. Brain Res 856 (2000) 254-258
8. Caceres A., and Taleisnik S. Dissociation of the inhibitory and facilitatory effects of norepinephrine on the release of LH by premammillary lesions. Neuroendocrinology 35 (1982) 98-103
9. Canuso C., Goldstein J.M., Wojcik J., Dawson R., Brandman D., Klibanski A., et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia. Psychiatry Res 111 (2002) 11-20
10. Caplan D., Gow D., and Makris N. Analysis of lesions by MRI in stroke patients with acoustic-phonetic processing deficits. Neurology 45 (1995) 293-298
11. Caviness V.S., Meyer J., Makris N., and Kennedy D.N. MRI-based topographic parcellation of human neocortex: An anatomically specified method with estimate of reliability. J Cogn Neurosci 8 (1996) 566-587
12. Cnaan A., Laird N.M., and Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 16 (1997) 2349-2380
13. Davison K., and Bagley C.R. Schizophrenia-like psychosis associated with organic disorders of the central nervous system: A review of the literature. Br J Psychiatry 4 (1969) 113-187
14. Dodson R.E., and Gorski R.A. Testosterone propionate administration prevents the loss of neurons within the central part of the medial preoptic nucleus. J Neurobiol 24 (1993) 80-88
15. Dorph-Petersen K.-A., Pierri J.N., Perel J.M., Zhuoxin S., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 (2005) 1649-1661
16. Faraone S.V., Seidman L.J., Kremen W.S., Pepple J.R., Lyons M.J., and Tsuang M.T. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis. J Abnorm Psychol 104 (1995) 286-304
17. Faraone S.V., Seidman L.J., Kremen W.S., Toomey R., Pepple J.R., and Tsuang M.T. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: The effect of genetic loading. Biol Psychiatry 48 (2000) 120-126
18. Farley I.J., Price K.S., McCullough E., Deck J.N., Hordynski W., and Hornykiewicz O. Norepinephrine in chronic paranoid schizophrenia: Above normal levels in limbic forebrain. Science 200 (1978) 456-457
19. Feldman S., Kreisel B., and Conforti N. Electrophysiological connections of the rat mediobasal hypothalamus with brain areas mediating adrenocortical responses. Brain Res Bull 1 (1976) 523-528
20. Filipek P.A., Richelme C., Kennedy D.N., and Caviness Jr. V.S. The young adult human brain: An MRI-based morphometric analysis. Cereb Cortex 4 (1994) 344-360
21. Frederikson M., Wik G., Fischer H., and Andersson J. Affective and attentive neural networks in humans: A PET study of Pavlovian conditioning. Neuroreport 7 (1995) 97-101
22. Geschwind N., and Galaburda A. Cerebral lateralization biological mechanisms, associations, and pathology: I. A hypothesis and a program for research. Arch Neurol 42 (1985) 428-459
23. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D., Makris N., Lee H., et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 56 (1999) 537-547
24. Goldstein J.M., Seidman L.J., Goodman J.M., Koren D., Lee H., Weintraub S., et al. Are there sex differences in neuropsychological functions among patients with schizophrenia?. Am J Psychiatry 155 (1998) 1358-1364
25. Goldstein J.M., Seidman L.J., Horton N.J., Makris N., Kennedy D.N., Caviness V.S., et al. Normal sexual dimorphism of the adult human brain assessed by in-vivo magnetic resonance imaging. Cereb Cortex 11 (2001) 490-497
26. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., et al. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry 59 (2002) 154-164
27. Gorski R.A. Sexual differentiation of the nervous system. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science (2000), McGraw-Hill Health Professions Division, New York, NY 1131-1146
28. Hafner H., Behrens S., and DeVry J. An animal model for the effects of estradiol on dopamine mediated behavior: Implications for sex differences in schizophrenia. Psychiatry Res 38 (1991) 125-134
29. Hammond J.Q., Le C., Goodyer M., Gelfand M., Frifiro M., and LeBlanc A. Testosterone mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem 77 (2001) 1319-1326
30. Hansen S., Ferreira A., and Selart M.E. Behavioural similarities between mother rats and benzodiazepine-treated non-maternal animals. Psychopharmacology (Berl) 86 (1985) 344-347
31. Huber P.J. The behavior of maximum likelihood estimates under non-standard conditions 1 (1967) 221-233 Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability
32. Ivanisevic-Milovanovic O.K., and Musicki B.D. Luteinization of ovaries and gonadotrophin and prolactin secretion in rats with posterior hypothalamic lesions. Endocr Regul 26 (1992) 89-93
33. Jastak J.F., and Jastak S. Wide Range Achievement Test-Revised (1985), Jastak Associates, Wilmington, DE
34. Jenkinson M., Bonnister P., Brady M., and Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 (2002) 825-841
35. Kataoka Y., Shibata K., Gomita Y., and Ueki S. The mammillary body is a potential site of antianxiety action of benzodiazepines. Brain Res 241 (1982) 374-377
36. Kawata M. Roles of steroid hormones and their receptors in structural organization in the nervous system. Neurosci Res 24 (1995) 1-46
37. Keshavan M.S., Montrose D.M., Pierri J.N., Dick E.L., Rosenberg D., Talagala L., and Sweeney J.A. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: Preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 21 (1997) 1285-1295
38. Kremen W.S., Seidman L.J., Faraone S.V., Pepple J.R., Lyons M.J., and Tsuang M.T. The "3 Rs" and neuropsychological function in schizophrenia: An empirical test of the matching fallacy. Neuropsychology 10 (1996) 22-31
39. Kulkarni J., Riedel A., de Castella A.R., Fitzgerald P.B., Rolfe T.J., Taffe J., et al. Estrogen-a potential treatment for schizophrenia. Schizophr Res 48 (2001) 137-144
40. Legros J.J., Gazzotti C., Carvelli T., Franchimont P., Timsit-Berthier M., von Frenckell R., et al. Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology 17 (1992) 611-617
41. Liang K.-Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
42. MacLusky N.J., Clark A.S., Naftolin F., and Goldman-Rakic P.S. Estrogen formation in the mammalian brain: Possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids 50 (1987) 459-474
43. Mai J.K., Berger K., and Sofroniew M.V. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: Pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J Hirnforsch 34 (1993) 133-154
44. Mesulam M.M. Patterns in behavioral neuroanatomy: Association areas, the limbic system, and hemispheric specialization. In: Mesulam M.M. (Ed). Principles of Behavioral Neurology (1985), Davis, Philadelphia 1-58
45. Morgan L.O., and Gregory H.S. Pathological changes in the tuber cinereum in a group of psychoses. J Nerv Ment Dis 82 (1935) 286-298
46. Nieto D., and Escobar A. Major psychoses. In: Minckler J. (Ed). Pathology of the Nervous System vol 3 (1972), McGraw-Hill, New York, NY 2654-2665
47. Nieuwenhuys R., Voogd J., and van Huijzen C. The Human Central Nervous System: A Synopsis and Atlas. 3rd ed. (1988), Springer-Verlag, Berlin, Germany
48. Nolte J. The Human Brain: An Introduction to Its Functional Anatomy (2002), Mosby, St. Louis, MO
49. Nurnberger J.J., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. Diagnostic Interview for Genetic Studies: Rationale, unique features, and training. Arch Gen Psychiatry 51 (1994) 842-869
50. Oades R.D., and Schepker R. Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 19 (1994) 373-385
51. Ostlund H., Keller E., and Hurd Y.L. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 1007 (2003) 54-63
52. Pacak K., Palkovits M., Kopin I.J., and Goldstein D.S. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: In vivo microdialysis studies. Front Neuroendocrinol 16 (1995) 89-150
53. Parent A. Carpenter's Human Neuroanatomy (1996), Williams and Wilkins, Media, PA
54. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., et al. Pituitary volume in psychosis. Br J Psychiatry 185 (2004) 5-10
55. Park J.-J., Baum M.J., Paredes R.G., and Tobet S.A. Neurogenesis and cell migration into the sexually dimorphic preoptic area/anterior hypothalamus of the fetal ferret. J Neurobiol 30 (1996) 315-328
56. Paxinos G., and Huang X. Atlas of the Human Brainstem (1995), Academic Press, San Diego, CA
57. Paxinos G., and Mai J.K. The Human Nervous System (2004), Academic Press, San Diego, CA
58. Pilgrim C., and Hutchison J.B. Developmental regulation of sex differences in the brain: Can the role of gonadal steroids be redefined?. Neuroscience 60 (1994) 843-855
59. Rademacher J., Galaburda A.M., Kennedy D.N., Filipek P.A., and Caviness V.S. Human cerebral cortex: Localization, parcellation, and morphometry with magnetic resonance imaging. J Cogn Neurosci 4 (1992) 352-374
60. Rauch S.L., Kim H., Makris N., Cosgrove G.R., Cassem E.H., Savage C.R., et al. Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: A morphometric magnetic resonance imaging study. J Neurosurg 93 (2000) 1019-1025
61. Riecher-Rossler A., Hafner H., Dutsch-Strobel A., and Stumbaum M. Gonadal function and its influence on psychopathology. Arch Women Ment Health 1 (1998) 15-26
62. Riecher-Rossler A., Hafner H., Stumbaum M., Maurer K., and Schmidt R. Can estradiol modulate schizophrenic symptomatology?. Schizophr Bull 20 (1994) 203-214
63. Roy A., Pickar D., Doran A., Wolkowitz O.M., Gallucci W., Chrousos G., et al. The corticotropin-releasing hormone stimulation test in chronic schizophrenia. Am J Psychiatry 143 (1986) 1393-1397
64. Saper C. Hypothalamus. In: Paxinos G., and Mai J.K. (Eds). The Human Nervous System (2004), Academic Press, San Diego, CA 513-561 chap 17
65. Seeman M.V., and Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 16 (1990) 185-194
66. Seidman L.J., Faraone S.V., Goldstein J.M., Goodman J.M., Kremen W.S., Toomey R., et al. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: An MRI-based morphometric analysis. Biol Psychiatry 46 (1999) 941-954
67. Seidman L.J., Faraone S.V., Goldstein J.M., Kremen W.S., Horton N.J., Makris N., et al. Left hippocampal volume as a vulnerability indicator for schizophrenia: An MRI morphometric study of non-psychotic first degree relatives. Arch Gen Psychiatry 59 (2002) 839-849
68. Seidman L.J., Goldstein J.M., Goodman J.M., Koren D., Turner W.M., Faraone S.V., et al. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: Relationship to attention and verbal ability. Biol Psychiatry 42 (1997) 104-115
69. Seidman L.J., Pantelis C., Keshavan M.S., Faraone S.V., Goldstein J.M., Horton N.J., et al. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: A magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull 29 (2003) 803-830
70. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry 45 (1999) 17-25
71. Shear P.K., Sullivan E.V., Lane B., and Pfefferbaum A. Mammillary body and cerebellar shrinkage in chronic alcoholics with and without amnesia. Alcohol Clin Exp Res 20 (1996) 1489-1495
72. Spitzer R., and Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS) (1978), Biometrics Research Department, New York State Psychiatric Institute, New York, NY
73. Spitzer R.L., Williams J.B.W., and Gibbon M. Structured Clinical Interview for DSM-III-R-Patient Version (1987), Biometrics Research Department, New York State Psychiatric Institute, New York, NY
74. Stevens J.R. Neuropathology of schizophrenia. Arch Gen Psychiatry 39 (1982) 1131-1139
75. Stewart J., and Rajabi H. Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat. Brain Res 646 (1994) 157-160
76. Suarez M., and Perassi N.I. Plasma corticosterone responses to lesions and stimulations of the limbic thalami nuclei, medial mammillary nucleus and cingulate cortex. Arch Int Physiol Biochim 96 (1988) 69-74
77. Sullivan E.V., Lane B., Deshmukh A., Rosenbloom M.J., Desmond J.E., Lim K.O., et al. In vivo mammillary body volume deficits in amnesic and nonamnesic alcoholics. Alcohol Clin Exp Res 23 (1999) 1629-1636
78. Swaab D.F. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). The Human Hypothalamus. Basic and Clinical Aspects. Part 1: Nuclei of the Hypothalamus. Handbook of Clinical Neurology, 3rd series vol 79 (2003), Elsevier, Amsterdam
79. Swaab D.F. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). The Human Hypothalamus. Basic and Clinical Aspects. Part 2: Neuropathology of the Hypothalamus and Adjacent Brain Structures. Handbook of Clinical Neurology, 3rd series vol 79 (2004), Elsevier, Amsterdam
80. Swaab D.F. Schizophrenia and autism. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). The Human Hypothalamus. Basic and Clinical Aspects. Part II: Neuropathology of the Hypothalamus and Adjacent Brain Structures. Handbook of Clinical Neurology, 3rd series vol 80 (2004), Elsevier, Amsterdam 289-299
81. Swaab D.F., and Fliers E. A sexually dimorphic nucleus in the human brain. Science 228 (1985) 1112-1115
82. Swanson L. The hypothalamus. Handbook of Chemical Neuroanatomy vol 5 (1987), Elsevier, New York, NY
83. Tobet S.A., Basham M.E., and Baum M.J. Estrogen receptor immunoreactive neurons in the fetal ferret forebrain. Brain Res Dev Brain Res 72 (1993) 167-180
84. Vaina L., Makris N., Kennedy D., and Cowey A. The selective impairment of the perception of first-order motion by unilateral cortical brian damage. Vis Neurosci 15 (1998) 333-348
85. Vincent K.R., Castillo I.M., Hauser R.I., Zapata J.A., Stuart H.J., Cohn C.K., et al. MMPI-168 Codebook (1984), Ablex, Norwood, NJ
86. Walder D.J., Walker E.F., and Lewine R.J. Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry 48 (2000) 1121-1132
87. Walker E.F., and Diforio D. Schizophrenia: A neural diathesis-stress model. Psychol Rev 104 (1997) 667-685
88. Walker E.F., Neumann C., Baum K.M., Davis D., Diforio D., and Bergman A. Developmental pathways to schizophrenia: Moderating effects of stress. Dev Psychopathol 8 (1996) 647-665
89. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1981), Psychological Corporation, San Antonio, TX
90. Williams L.M., Das P., Harris A.W., Liddell B.B., Brammer M.J., Olivieri G., et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 161 (2004) 480-489
91. Zhou J.N., Hofman M.A., Gooren L.J., and Swaab D.F. A sex difference in the human brain and its relation to transsexuality. Nature 378 (1995) 68-70